(ECL) Ecolab - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2788651006

ECL: Water Treatment, Cleaning Solutions, Sanitizing Products, Pest Elimination Services

Ecolab Inc. (NYSE:ECL) is a global leader in water, hygiene, and infection prevention solutions. Founded in 1923 and headquartered in Saint Paul, Minnesota, the company operates through three core segments: Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences. Its diverse product portfolio addresses critical needs across industries, from water treatment and process optimization to cleaning, sanitizing, and infection control.

The Global Industrial segment serves a wide range of industries, including manufacturing, food and beverage processing, transportation, chemical, metals, mining, power generation, and petrochemicals. Ecolab’s solutions here focus on water treatment, process applications, and cleaning technologies that enhance efficiency and sustainability. This segment is pivotal for industries where water scarcity and contamination are operational risks.

The Global Institutional & Specialty segment caters to the foodservice, hospitality, lodging, government, education, and retail sectors. Ecolab provides specialized cleaning and sanitizing products that are essential for maintaining public health and safety standards. This segment is deeply integrated into the daily operations of its customers, offering tailored solutions to prevent the spread of pathogens and ensure regulatory compliance.

The Global Healthcare & Life Sciences segment is a cornerstone of Ecolab’s business, serving healthcare, personal care, and pharmaceutical industries. Under brands like Ecolab, Microtek, and Anios, the company delivers infection prevention solutions, surgical products, and contamination control services. This segment is critical for healthcare facilities and life sciences companies, where maintaining sterile environments is paramount.

Ecolab also offers pest elimination services, addressing the detection, elimination, and prevention of rodents and insects in commercial settings such as restaurants, food processors, hotels, and grocery operations. Additionally, the company provides colloidal silica products used in semiconductor manufacturing, catalyst production, and aerospace components. Its portfolio is complemented by water and energy management programs, custom-designed wash process solutions, and real-time data management tools.

From a financial perspective, Ecolab is a large-cap company with a market capitalization of approximately $75.17 billion. Its current P/E ratio of 35.97 reflects its premium valuation,

Additional Sources for ECL Stock

ECL Stock Overview

Market Cap in USD 75,171m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception 1988-01-05

ECL Stock Ratings

Growth 5y 33.4%
Fundamental 47.1%
Dividend 54.7%
Rel. Strength Industry 14
Analysts 3.73/5
Fair Price Momentum 234.67 USD
Fair Price DCF 50.27 USD

ECL Dividends

Dividend Yield 12m 0.89%
Yield on Cost 5y 1.20%
Annual Growth 5y 4.54%
Payout Consistency 96.7%

ECL Growth Ratios

Growth Correlation 3m 20.9%
Growth Correlation 12m 73%
Growth Correlation 5y 27.2%
CAGR 5y 6.25%
CAGR/Mean DD 5y 0.42
Sharpe Ratio 12m 1.09
Alpha 4.13
Beta 0.83
Volatility 18.18%
Current Volume 1265.2k
Average Volume 20d 1284.2k
What is the price of ECL stocks?
As of February 19, 2025, the stock is trading at USD 266.22 with a total of 1,265,218 shares traded.
Over the past week, the price has changed by +1.91%, over one month by +10.43%, over three months by +8.52% and over the past year by +24.23%.
Is Ecolab a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Ecolab (NYSE:ECL) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.07 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ECL as of February 2025 is 234.67. This means that ECL is currently overvalued and has a potential downside of -11.85%.
Is ECL a buy, sell or hold?
Ecolab has received a consensus analysts rating of 3.73. Therefor, it is recommend to hold ECL.
  • Strong Buy: 8
  • Buy: 4
  • Hold: 13
  • Sell: 1
  • Strong Sell: 0
What are the forecast for ECL stock price target?
According to ValueRays Forecast Model, ECL Ecolab will be worth about 281.6 in February 2026. The stock is currently trading at 266.22. This means that the stock has a potential upside of +5.78%.
Issuer Forecast Upside
Wallstreet Target Price 280.9 5.5%
Analysts Target Price 272.4 2.3%
ValueRay Target Price 281.6 5.8%